Amid the controversy over the false positive GM (galactomannan) test due to total parenteral nutrition (TPN) products using Chinese glucose, makers are going all out to calm jitters by recalling products from hospitals.According to pharmaceutical industry sources, the Korean pharma companies that ma
Ono Pharmaceutical Korea and BMS Pharmaceutical Korea said on Monday that Opdivo (ingredient: nivolumab), an anti-PD-1 monoclonal antibody, was approved as a combination of two treatments for progressive or metastatic esophageal squamous cell cancer (ESCC) by the Ministry of Food and Drug Safety.Bot
Cellivery Therapeutics, a Korean biotech firm, warned its investors Friday that it could be delisted because it received a disclaimer of opinion from its outside auditor. This led to a trading suspension for the company's shares on the tech-heavy Kosdaq market on the same day.Grant Thornton, which p
Spectrum Pharmaceuticals (SPPI), the U.S. partner of Hanmi Pharm, recorded $10.1 million (13 billion won) in sales in the first year of releasing Rolontis (eflapegrastim with the U.S. product name of Rolvedon), a neutropenia treatment, in the U.S. market.On Wednesday (local time), the company unveil
Tagrisso (osimertinib), AstraZeneca’s targeted agent that dominates the global EGFR (epidermal growth factor receptor)-mutant NSCLC (non-small cell lung cancer) treatment market, could face a threatening challenge from a latecomer this year, a market surveyor said.According to a recent report of Eva
CG Bio said it has signed a contract to export $8 million worth of Aileene, its hyaluronic acid (HA) filler, to Australia and New Zealand through Amore Aesthetics.Amore Aesthetics is a franchise company affiliated with Haus Cosmetics, a leading medical spa brand in Australia and New Zealand. The com
Lemonex, a company pioneering mRNA and siRNA therapeutics, said on Thursday that it will unveil the preclinical results of its next-generation drug delivery system (DDS) and Covid-19 mRNA vaccine candidate at the Global Vaccine and Immunization Research Forum (GVIRF), scheduled to be held in Incheon
Dongwon Industries, the biggest tinned tuna seller in Korea that recently drew attention by expressing an intention to jump into the biopharmaceutical business, abruptly gave up acquiring Boryung Biopharma, raising questions about its background.In a public filing on Wednesday, Dongwon said it had d
The combination therapy of immunotherapy zolbetuximab and CAPOX (capecitabine + oxaliplatin) developed by Astellas is drawing attention by showing positive clinical results in Claudin (CLDN)18.2+ and HER2- progressive gastric and gastroesophageal junction (GEJ) adenocarcinoma.On Tuesday (local time)
Takeda Korea said Wednesday that it received approval for Obizur, a treatment for bleeding in adult patients with acquired hemophilia A (AHA), from the Ministry of Food and Drug Safety.AHA is a disease characterized by the development of autoimmune antibodies against blood coagulation factor 8, resu
Moderna said on Wednesday that it signed a memorandum of understanding (MOU) with Korea mRNA Vaccine Initiative (KmVAC), a Korean government program, to pursue collaborative vaccine R&D and mutual cooperation.Under the MOU, Moderna and KmVAC will establish a cooperative relationship and activate rel
Pfizer is diversifying the applications and formulations of Xeljanz (tofacitinib) to differentiate its JAK inhibitor from generic products.On Monday, the Ministry of Food and Drug Safety approved using Xeljanz Syrup 1mg/mL to treat polyarticular juvenile idiopathic arthritis (pJIA) and juvenile psor
Kangbuk Samsung Hospital said on Tuesday it was selected by the Korea International Cooperation Agency (KOICA) for the "Capacity Building and Medical Infrastructure Improvement Project to Improve Health Standards of the Poor in the Vulnerable Areas of Bhaktapur, Nepal".Accordingly, Kangbuk Samsung H
Boryung, traditionally known for its pharma business, said it would establish a joint venture (JV) with Axiom Space, a U.S.-based space infrastructure developer, in Korea to invest in healthcare in space."We agreed to establish a JV with Axiom Space on Monday," Boryung CEO Jay Kim said at the compan
GC said it has won a $43.38 million contract with Pan American Health Organization (PAHO) to supply its influenza vaccine to Latin America.The vaccines will be supplied to Latin American countries in the first half of the year.With the latest bidding win, GC maintained the top market share position
Over the past decade, PARP inhibitors have emerged as the main trend in the ovarian cancer treatment market. And two drugs -- Lynparza (olaparib) and Zejula (niraparib) -- divide the market.First runner Lynparza drew attention by treating patients with specific genetic mutations. In contrast, lateco
In the contracted drug quantity, a yardstick of the prescription rate by Seoul National University Hospital (SNUH), GSK’s HIV treatment Dovato (dolutegravir/lamivudine) has surpassed Gilead’s Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide, B/F/TAF).According to the integrated bidding anno
Prestige Biopharma said on Thursday that its new pancreatic cancer antibody drug candidate, PBP1510, (ingredient: ulenistamab), was granted FDA Fast Track designation.PBP1510 specifically binds to PAUF and exerts anti-metastasis and immune modulation effects. Pancreatic cancer generally expresses a
Biopharma companies with GLP-1 (glucagon-like peptide-1) analogs, which have become a new trend in the obesity treatment market long dominated by appetite suppressants and fat-absorbance inhibitors, are upgrading their treatments.One of the latest GLP-1 analogs under development is drawing particula
Hanmi Pharmaceutical said it plans to participate in the 2023 BIO-Europe Spring Conference, where it will kick off its CMO (contract manufacturing organization) and CDMO (contract development and manufacturing organization) business in earnest.By synergizing its development capabilities accumulated